PEPTONIC Medical AB today announced that the company has signed a license agreement with Swiss medical device company Prima Lab SA for the sale of self-tests for measurement of FSH hormone in Sweden.
The agreement means that Peptonic gets the right to sell Prima Lab’s self-test for FSH hormone under its own brand VagiVital® in Sweden, with a planned launch in early 2024.
Today, about one million women in Sweden are in menopause. Menopause brings problems to varying degrees such as vaginal dryness, sweating, hot flushes and more subtle symptoms such as concentration and memory difficulties.
“It is not easy to know if you are in menopause or not, and there are also so many different diffuse symptoms that can be related to this phase of life. A self-test that indicates if you are in menopause can provide a reassuring answer that also helps you understand the cause of the unclear problems that may arise,” said Fanny Falkman Grinndal, Country Manager Sweden at Peptonic.
Prima Lab is a Swiss medical technology company with a specific focus on self-tests for women’s health. The company has its own development and sells its products in more than thirty countries around the world. During menopause, elevated FSH values are common, which is why a test that measures this is a good indicator.
Prima Lab is already a strategic partner to Peptonic as it sells Peptonic’s patented test for amniocentesis in a number of selected markets in Europe and out-license a urinary tract infection test that will be launched at the end of the year on the Swedish market by Peptonic.
“To continue to deepen the collaboration with Prima Lab, which is a leading player in self-tests for women’s health, is a very valuable step as we continue to build our portfolio according to the principle of diagnose, treat and prevent,” said Erik Sundquist, CEO of Peptonic.
“Peptonic is a growing and important player in women’s health, and we see the fact that the company is now introducing our self-test for FSH hormone on the Swedish market as very valuable for our continued expansion,” said Prima Lab’s CEO and founder Federico Roveda.
About Prima Lab
Prima Lab’s vision is to create a world where diseases are identified before medical treatments are needed, and in this way the company works preventively. It does this by focusing on clinically proven self-tests in a number of therapeutic areas. The company was founded in 2014 and has since grown very rapidly and now has more than 200 products sold in more than 30 countries. The head office is located in Balerna, Switzerland, where they conduct development, production and sales. For more information see https://primalabsa.ch/en/
About Peptonic Medical AB
Peptonic is a Swedish innovative biomedical company that conducts research, development and sales of medical treatments and lifestyle products in the field of women’s health. Peptonic has divided its operations into two business areas: “Medical Consumer” and “Lifestyle Consumer”. The business area “Medical Consumer” is based on clinically proven intimate self-care and constitutes the company’s main focus and is sold under the VagiVital® brand. The “Lifestyle Consumer” business area consists of lifestyle products with a focus on sustainable menstrual products and is sold under the Lunette® brand. The company was founded in 2009 and the stock has been traded since 2014 on Spotlight (www.spotlightstockmarket.com) in Stockholm. More information about Peptonic Medical is available on www.peptonicmedical.se.
Erik Sundquist, CEO
Telefon: + 46 722 49 90 43
